Exceptional maintenance data strengthens ResPeg profile
The bull case was strengthened by ResPeg's strong maintenance data, showing a high percentage of patients maintained response with a convenient dosing schedule of just four shots a year.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.